Alzheimer's care patients suffer from irreversible, progressive brain damage that destroys memory and thinking skills. A team of scientists in New York is now doing what it can to end Alzheimer's disease (AD).
Jin Ryoun Kim, an assistant professor of chemical and biological engineering at the Polytechnic Institute of New York University, is leading a team of researchers who believe developing a biochemical probe that reveals the toxic proteins associated with Alzheimer's could help fight the disease.
Such an instrument would allow doctors to develop drugs that could prevent AD.
"One of the biggest problems in AD research is the instability of these toxic protein forms," said Kim. "It's very likely that any existing method of finding them might be misleading; that is, it's like going after a moving target."
The Mayo Clinic says AD is the most common form of dementia. While only 5 percent of people between the ages of 65 and 74 have Alzheimer's, 50 percent of seniors over the age of 85 suffer from the incurable disease.